Skip to content
★ Sign in to follow
CA

Charles Albright

Editas Medicine, Inc.
Total declarations
25
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (16 ops.)
€3.1M

Latest filing published 17 Dec 2020 for Editas Medicine, Inc., €298k.

Filing timeline

BuySale
Charles Albright

Insider track record

Disclosed buys
0
Disclosed sells
16
Signal history

Charles Albright: trading record in brief

All filings by Charles Albright on record concern Editas Medicine, Inc. Between 23 May 2018 and 15 December 2020, the trades on record add up to 25 filings.

Sales make up the whole of the open-market record (16 sales, €3.1M). The rest of the record consists of 1 share grant and 8 option exercises. So far in 2020, the count stands at no purchases and 14 sales.

The latest filing, published on 17 December 2020, reports an open-market sale of €298k in Editas Medicine, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Charles Albright

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations25 total

25 of 25 declarations